Fluconazole Kabi

Fluconazole Kabi is an antifungal medication used to treat various fungal infections. This intravenous formulation is manufactured by Fresenius Kabi Polska Sp. z o.o. and is suitable for hospital use.

Fluconazole Kabi is primarily used to treat fungal infections, including candidiasis and cryptococcal meningitis. It is often prescribed for patients who cannot take oral medications. The intravenous form allows for direct administration into the bloodstream, ensuring rapid absorption and effectiveness. Healthcare professionals determine the specific uses based on individual patient needs.

Common effects of Fluconazole Kabi may include headache, dizziness, and gastrointestinal issues such as nausea or diarrhea. Some patients may experience skin rashes or allergic reactions. These effects vary among individuals and should be discussed with a healthcare provider.

Fluconazole Kabi should be used with caution in patients with liver or kidney disease. It is important to inform healthcare providers about any existing medical conditions or allergies before starting treatment. Proper administration techniques should be followed to minimize the risk of infection at the injection site.

Fluconazole Kabi may interact with certain medications, including those metabolized by the liver's cytochrome P450 system. It is advisable to avoid alcohol while using this medication, as it can increase the risk of side effects. Always consult a healthcare provider before combining Fluconazole Kabi with other medications.